Website profile

Pharmaceutical Executive

Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.

  • 913articles · 365d
  • 8+ hour agolatest article
  • Sep 14, 2025earliest in window
  • 95%with images
  • 285avg words
articles per day
Categories
  • Medical 573
  • Business & Industrial 538
  • Economy, Business & Finance 451
  • Health & Wellness 337
  • Health 267
  • Finance & Business 254
  • Science & Technology 156
  • Science & Nature 42

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

PharmExec
pharmexec.com > view > agentic-ai-revolution-biopharma

The Agentic AI Revolution in Biopharma

2+ day, 8+ hour ago   (1556+ words) How agentic artificial intelligence is transforming the value chain from discovery to commercialization. The biopharmaceutical industry is undergoing a profound transformation, driven by the emergence of agentic artificial intelligence (AI). Unlike traditional AI models that require continuous human guidance, agentic…...

PharmExec
pharmexec.com > view > life-sciences-companies-real-impact-patient-engagement

How Life Sciences Companies Can Create Real Impact With Patient Engagement

2+ day, 14+ hour ago   (165+ words) A “maturity curve” can help organizations move engagement beyond performative gestures to a strategic asset. For more than 20 years now, companies in the life sciences industry have waved the banner of patient-centricity, spending on advisory boards, listening sessions and even…...

Pharmaceutical Executive
pharmexec.com > shorts > unlocking-future-real-world-data-research

Unlocking the Future of Real-World Data & Research | PharmExec

3+ day, 20+ hour ago   (40+ words) Unlocking the Future of Real-World Data & Research Pharmaceutical Executive Pharmaceutical Executive Daily: Moonwalk Biosciences' $70 Million Series B Trusted Research Environments Are Reshaping Real-World Data Access: Q&A with Mark Cziraky FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults...

PharmExec
pharmexec.com > view > trump-administration-adds-nine-drugmakers-most-favored-nation-program-report

Trump Administration Adds Nine Drugmakers to Most-Favored-Nation Program: Report

1+ week, 5+ day ago   (189+ words) The Trump administration adds nine midsize pharmaceutical companies, including Teva, UCB, Astellas, and BeOne Medicines to its Most-Favored-Nation drug pricing program. President Donald J. Trump announced nine new agreements with pharmaceutical manufacturers to lower prescription drug prices for Americans. Commonly known…...

Pharmaceutical Executive
pharmexec.com > shorts > global-science-innovation-shifting-asia

Why Global Science Innovation is Shifting to Asia | PharmExec

2+ week, 3+ day ago   (57+ words) Why Global Science Innovation is Shifting to Asia Pharmaceutical Executive Pharmaceutical Executive Daily: FDA Approves Imaavy for wAIHA What Executives and Investors Are Looking for in Pharma Companies FDA Approves Imaavy for Warm Autoimmune Hemolytic Anemia in Patients Aged 12 and…...

PharmExec
pharmexec.com > view > retailization-medicare-advantage-costco-pharma

The Retailization of Medicare Advantage: What Costco???s Entry Means for Pharma

2+ week, 4+ day ago   (1202+ words) Costco’s partnership with SCAN Group suggests that the next competitive advantage in Medicare may come not only from managing insurance risk, but from controlling a trusted consumer healthcare ecosystem. Medicare Advantage has become a tougher business just as Costco is…...

PharmExec
pharmexec.com > view > fda-approves-imaavy-warm-autoimmune-hemolytic-anemia-aged-12-older

FDA Approves Imaavy for Warm Autoimmune Hemolytic Anemia in Patients Aged 12 and Older

2+ week, 4+ day ago   (219+ words) FDA approved Imaavy (nipocalimab-aahu) as the first-ever treatment specifically indicated for warm autoimmune hemolytic anemia in patients ages 12 and up. FDA approved Imaavy (nipocalimab-aahu) for the treatment of warm autoimmune hemolytic anemia in adults and pediatric patients 12 years of age…...

PharmExec
pharmexec.com > view > infrastructure-first-a-framework-for-scaling-ai-in-life-sciences

Infrastructure First: A Framework for Scaling AI in Life Sciences

2+ week, 5+ day ago   (219+ words) You've seen it before: an AI pilot that works in testing, then stalls the moment someone asks you to reproduce the result. The cause usually isn't the model—it's what wasn't built around it. Komodo Health built this framework from…...

PharmExec
pharmexec.com > view > roundup-amplitude-therapeutics-chai-discovery-collaborations-eli-lilly-bristol-myers-squibb

Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb

3+ week, 1+ day ago   (340+ words) Amplitude Therapeutics enters a collaboration with Eli Lilly to develop trans-amplifying RNA vaccines, while Chai Discovery partners with Bristol Myers Squibb to deploy its AI molecular folding and design models across BMS's antibody discovery portfolio. As of August 21, financial terms…...

PharmExec
pharmexec.com > view > fda-approves-pasatru-adults-fibrodysplasia-ossificans-progressiva

FDA Approves Pasatru For Adults With Fibrodysplasia Ossificans Progressiva

3+ week, 2+ day ago   (548+ words) Pharmaceutical Executive Regeneron Pharmaceuticals received FDA approval for Pasatru (garetosmab-grts) to reduce the formation of new heterotopic ossification (HO) lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva (FOP) FOP is an ultra-rare genetic disorder in which muscles, tendons,…...